img

Global Children Long-Acting Growth Hormone Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Children Long-Acting Growth Hormone Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Children Long-Acting Growth Hormone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Children Long-Acting Growth Hormone market research.
Key manufacturers engaged in the Children Long-Acting Growth Hormone industry include Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen, LG Life Sciences and Sandoz International, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Children Long-Acting Growth Hormone were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Children Long-Acting Growth Hormone market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Children Long-Acting Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent

Segment by Application


Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Children Long-Acting Growth Hormone report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Children Long-Acting Growth Hormone Market Overview
1.1 Product Overview and Scope of Children Long-Acting Growth Hormone
1.2 Children Long-Acting Growth Hormone Segment by Type
1.2.1 Global Children Long-Acting Growth Hormone Market Value Comparison by Type (2024-2034)
1.2.2 Powder
1.2.3 Solvent
1.3 Children Long-Acting Growth Hormone Segment by Application
1.3.1 Global Children Long-Acting Growth Hormone Market Value by Application: (2024-2034)
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age(SGA)
1.3.7 Others
1.4 Global Children Long-Acting Growth Hormone Market Size Estimates and Forecasts
1.4.1 Global Children Long-Acting Growth Hormone Revenue 2024-2034
1.4.2 Global Children Long-Acting Growth Hormone Sales 2024-2034
1.4.3 Global Children Long-Acting Growth Hormone Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Children Long-Acting Growth Hormone Market Competition by Manufacturers
2.1 Global Children Long-Acting Growth Hormone Sales Market Share by Manufacturers (2024-2024)
2.2 Global Children Long-Acting Growth Hormone Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Children Long-Acting Growth Hormone Average Price by Manufacturers (2024-2024)
2.4 Global Children Long-Acting Growth Hormone Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Children Long-Acting Growth Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children Long-Acting Growth Hormone, Product Type & Application
2.7 Children Long-Acting Growth Hormone Market Competitive Situation and Trends
2.7.1 Children Long-Acting Growth Hormone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Children Long-Acting Growth Hormone Players Market Share by Revenue
2.7.3 Global Children Long-Acting Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Children Long-Acting Growth Hormone Retrospective Market Scenario by Region
3.1 Global Children Long-Acting Growth Hormone Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Children Long-Acting Growth Hormone Global Children Long-Acting Growth Hormone Sales by Region: 2024-2034
3.2.1 Global Children Long-Acting Growth Hormone Sales by Region: 2024-2024
3.2.2 Global Children Long-Acting Growth Hormone Sales by Region: 2024-2034
3.3 Global Children Long-Acting Growth Hormone Global Children Long-Acting Growth Hormone Revenue by Region: 2024-2034
3.3.1 Global Children Long-Acting Growth Hormone Revenue by Region: 2024-2024
3.3.2 Global Children Long-Acting Growth Hormone Revenue by Region: 2024-2034
3.4 North America Children Long-Acting Growth Hormone Market Facts & Figures by Country
3.4.1 North America Children Long-Acting Growth Hormone Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Children Long-Acting Growth Hormone Sales by Country (2024-2034)
3.4.3 North America Children Long-Acting Growth Hormone Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children Long-Acting Growth Hormone Market Facts & Figures by Country
3.5.1 Europe Children Long-Acting Growth Hormone Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Children Long-Acting Growth Hormone Sales by Country (2024-2034)
3.5.3 Europe Children Long-Acting Growth Hormone Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children Long-Acting Growth Hormone Market Facts & Figures by Country
3.6.1 Asia Pacific Children Long-Acting Growth Hormone Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Children Long-Acting Growth Hormone Sales by Country (2024-2034)
3.6.3 Asia Pacific Children Long-Acting Growth Hormone Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Children Long-Acting Growth Hormone Market Facts & Figures by Country
3.7.1 Latin America Children Long-Acting Growth Hormone Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Children Long-Acting Growth Hormone Sales by Country (2024-2034)
3.7.3 Latin America Children Long-Acting Growth Hormone Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Children Long-Acting Growth Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Children Long-Acting Growth Hormone Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Children Long-Acting Growth Hormone Sales by Country (2024-2034)
3.8.3 Middle East and Africa Children Long-Acting Growth Hormone Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children Long-Acting Growth Hormone Sales by Type (2024-2034)
4.1.1 Global Children Long-Acting Growth Hormone Sales by Type (2024-2024)
4.1.2 Global Children Long-Acting Growth Hormone Sales by Type (2024-2034)
4.1.3 Global Children Long-Acting Growth Hormone Sales Market Share by Type (2024-2034)
4.2 Global Children Long-Acting Growth Hormone Revenue by Type (2024-2034)
4.2.1 Global Children Long-Acting Growth Hormone Revenue by Type (2024-2024)
4.2.2 Global Children Long-Acting Growth Hormone Revenue by Type (2024-2034)
4.2.3 Global Children Long-Acting Growth Hormone Revenue Market Share by Type (2024-2034)
4.3 Global Children Long-Acting Growth Hormone Price by Type (2024-2034)
5 Segment by Application
5.1 Global Children Long-Acting Growth Hormone Sales by Application (2024-2034)
5.1.1 Global Children Long-Acting Growth Hormone Sales by Application (2024-2024)
5.1.2 Global Children Long-Acting Growth Hormone Sales by Application (2024-2034)
5.1.3 Global Children Long-Acting Growth Hormone Sales Market Share by Application (2024-2034)
5.2 Global Children Long-Acting Growth Hormone Revenue by Application (2024-2034)
5.2.1 Global Children Long-Acting Growth Hormone Revenue by Application (2024-2024)
5.2.2 Global Children Long-Acting Growth Hormone Revenue by Application (2024-2034)
5.2.3 Global Children Long-Acting Growth Hormone Revenue Market Share by Application (2024-2034)
5.3 Global Children Long-Acting Growth Hormone Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Pfizer Children Long-Acting Growth Hormone Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Novo Nordisk Children Long-Acting Growth Hormone Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Eli Lilly Children Long-Acting Growth Hormone Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck Serono
6.4.1 Merck Serono Corporation Information
6.4.2 Merck Serono Description and Business Overview
6.4.3 Merck Serono Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Merck Serono Children Long-Acting Growth Hormone Product Portfolio
6.4.5 Merck Serono Recent Developments/Updates
6.5 F. Hoffmann-La Roche
6.5.1 F. Hoffmann-La Roche Corporation Information
6.5.2 F. Hoffmann-La Roche Description and Business Overview
6.5.3 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.5.4 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Product Portfolio
6.5.5 F. Hoffmann-La Roche Recent Developments/Updates
6.6 Ferring Pharmaceuticals
6.6.1 Ferring Pharmaceuticals Corporation Information
6.6.2 Ferring Pharmaceuticals Description and Business Overview
6.6.3 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Product Portfolio
6.6.5 Ferring Pharmaceuticals Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Ipsen Children Long-Acting Growth Hormone Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.8.4 LG Life Sciences Children Long-Acting Growth Hormone Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Sandoz International
6.9.1 Sandoz International Corporation Information
6.9.2 Sandoz International Description and Business Overview
6.9.3 Sandoz International Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Sandoz International Children Long-Acting Growth Hormone Product Portfolio
6.9.5 Sandoz International Recent Developments/Updates
6.10 Anhui Anke Biotechnology
6.10.1 Anhui Anke Biotechnology Corporation Information
6.10.2 Anhui Anke Biotechnology Description and Business Overview
6.10.3 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Product Portfolio
6.10.5 Anhui Anke Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children Long-Acting Growth Hormone Industry Chain Analysis
7.2 Children Long-Acting Growth Hormone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children Long-Acting Growth Hormone Production Mode & Process
7.4 Children Long-Acting Growth Hormone Sales and Marketing
7.4.1 Children Long-Acting Growth Hormone Sales Channels
7.4.2 Children Long-Acting Growth Hormone Distributors
7.5 Children Long-Acting Growth Hormone Customers
8 Children Long-Acting Growth Hormone Market Dynamics
8.1 Children Long-Acting Growth Hormone Industry Trends
8.2 Children Long-Acting Growth Hormone Market Drivers
8.3 Children Long-Acting Growth Hormone Market Challenges
8.4 Children Long-Acting Growth Hormone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Children Long-Acting Growth Hormone Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Children Long-Acting Growth Hormone Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Children Long-Acting Growth Hormone Market Competitive Situation by Manufacturers in 2022
Table 4. Global Children Long-Acting Growth Hormone Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Children Long-Acting Growth Hormone Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Children Long-Acting Growth Hormone Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Children Long-Acting Growth Hormone Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Children Long-Acting Growth Hormone Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Children Long-Acting Growth Hormone, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Children Long-Acting Growth Hormone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Children Long-Acting Growth Hormone, Product Type & Application
Table 12. Global Key Manufacturers of Children Long-Acting Growth Hormone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Children Long-Acting Growth Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Long-Acting Growth Hormone as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Children Long-Acting Growth Hormone Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Children Long-Acting Growth Hormone Sales by Region (2024-2024) & (K Units)
Table 18. Global Children Long-Acting Growth Hormone Sales Market Share by Region (2024-2024)
Table 19. Global Children Long-Acting Growth Hormone Sales by Region (2024-2034) & (K Units)
Table 20. Global Children Long-Acting Growth Hormone Sales Market Share by Region (2024-2034)
Table 21. Global Children Long-Acting Growth Hormone Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Children Long-Acting Growth Hormone Revenue Market Share by Region (2024-2024)
Table 23. Global Children Long-Acting Growth Hormone Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Children Long-Acting Growth Hormone Revenue Market Share by Region (2024-2034)
Table 25. North America Children Long-Acting Growth Hormone Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Children Long-Acting Growth Hormone Sales by Country (2024-2024) & (K Units)
Table 27. North America Children Long-Acting Growth Hormone Sales by Country (2024-2034) & (K Units)
Table 28. North America Children Long-Acting Growth Hormone Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Children Long-Acting Growth Hormone Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Children Long-Acting Growth Hormone Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Children Long-Acting Growth Hormone Sales by Country (2024-2024) & (K Units)
Table 32. Europe Children Long-Acting Growth Hormone Sales by Country (2024-2034) & (K Units)
Table 33. Europe Children Long-Acting Growth Hormone Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Children Long-Acting Growth Hormone Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Children Long-Acting Growth Hormone Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Children Long-Acting Growth Hormone Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Children Long-Acting Growth Hormone Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Children Long-Acting Growth Hormone Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Children Long-Acting Growth Hormone Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Children Long-Acting Growth Hormone Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Children Long-Acting Growth Hormone Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Children Long-Acting Growth Hormone Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Children Long-Acting Growth Hormone Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Children Long-Acting Growth Hormone Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Children Long-Acting Growth Hormone Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Children Long-Acting Growth Hormone Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Children Long-Acting Growth Hormone Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Children Long-Acting Growth Hormone Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Children Long-Acting Growth Hormone Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Children Long-Acting Growth Hormone Sales (K Units) by Type (2024-2024)
Table 51. Global Children Long-Acting Growth Hormone Sales (K Units) by Type (2024-2034)
Table 52. Global Children Long-Acting Growth Hormone Sales Market Share by Type (2024-2024)
Table 53. Global Children Long-Acting Growth Hormone Sales Market Share by Type (2024-2034)
Table 54. Global Children Long-Acting Growth Hormone Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Children Long-Acting Growth Hormone Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Children Long-Acting Growth Hormone Revenue Market Share by Type (2024-2024)
Table 57. Global Children Long-Acting Growth Hormone Revenue Market Share by Type (2024-2034)
Table 58. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Type (2024-2024)
Table 59. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Type (2024-2034)
Table 60. Global Children Long-Acting Growth Hormone Sales (K Units) by Application (2024-2024)
Table 61. Global Children Long-Acting Growth Hormone Sales (K Units) by Application (2024-2034)
Table 62. Global Children Long-Acting Growth Hormone Sales Market Share by Application (2024-2024)
Table 63. Global Children Long-Acting Growth Hormone Sales Market Share by Application (2024-2034)
Table 64. Global Children Long-Acting Growth Hormone Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Children Long-Acting Growth Hormone Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Children Long-Acting Growth Hormone Revenue Market Share by Application (2024-2024)
Table 67. Global Children Long-Acting Growth Hormone Revenue Market Share by Application (2024-2034)
Table 68. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Application (2024-2024)
Table 69. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Pfizer Children Long-Acting Growth Hormone Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Novo Nordisk Children Long-Acting Growth Hormone Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Eli Lilly Children Long-Acting Growth Hormone Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Merck Serono Corporation Information
Table 86. Merck Serono Description and Business Overview
Table 87. Merck Serono Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Merck Serono Children Long-Acting Growth Hormone Product
Table 89. Merck Serono Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Corporation Information
Table 91. F. Hoffmann-La Roche Description and Business Overview
Table 92. F. Hoffmann-La Roche Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. F. Hoffmann-La Roche Children Long-Acting Growth Hormone Product
Table 94. F. Hoffmann-La Roche Recent Developments/Updates
Table 95. Ferring Pharmaceuticals Corporation Information
Table 96. Ferring Pharmaceuticals Description and Business Overview
Table 97. Ferring Pharmaceuticals Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Ferring Pharmaceuticals Children Long-Acting Growth Hormone Product
Table 99. Ferring Pharmaceuticals Recent Developments/Updates
Table 100. Ipsen Corporation Information
Table 101. Ipsen Description and Business Overview
Table 102. Ipsen Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Ipsen Children Long-Acting Growth Hormone Product
Table 104. Ipsen Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. LG Life Sciences Children Long-Acting Growth Hormone Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Sandoz International Corporation Information
Table 111. Sandoz International Description and Business Overview
Table 112. Sandoz International Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Sandoz International Children Long-Acting Growth Hormone Product
Table 114. Sandoz International Recent Developments/Updates
Table 115. Anhui Anke Biotechnology Corporation Information
Table 116. Anhui Anke Biotechnology Description and Business Overview
Table 117. Anhui Anke Biotechnology Children Long-Acting Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Anhui Anke Biotechnology Children Long-Acting Growth Hormone Product
Table 119. Anhui Anke Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Children Long-Acting Growth Hormone Distributors List
Table 123. Children Long-Acting Growth Hormone Customers List
Table 124. Children Long-Acting Growth Hormone Market Trends
Table 125. Children Long-Acting Growth Hormone Market Drivers
Table 126. Children Long-Acting Growth Hormone Market Challenges
Table 127. Children Long-Acting Growth Hormone Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Children Long-Acting Growth Hormone
Figure 2. Global Children Long-Acting Growth Hormone Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Children Long-Acting Growth Hormone Market Share by Type in 2022 & 2034
Figure 4. Powder Product Picture
Figure 5. Solvent Product Picture
Figure 6. Global Children Long-Acting Growth Hormone Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Children Long-Acting Growth Hormone Market Share by Application in 2022 & 2034
Figure 8. Growth Hormone Deficiency (GHD)
Figure 9. Turner Syndrome
Figure 10. Chronic Renal Insufficiency
Figure 11. Prader Willi Syndrome
Figure 12. Small for Gestational Age(SGA)
Figure 13. Others
Figure 14. Global Children Long-Acting Growth Hormone Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Children Long-Acting Growth Hormone Market Size (2024-2034) & (US$ Million)
Figure 16. Global Children Long-Acting Growth Hormone Sales (2024-2034) & (K Units)
Figure 17. Global Children Long-Acting Growth Hormone Average Price (US$/Unit) & (2024-2034)
Figure 18. Children Long-Acting Growth Hormone Report Years Considered
Figure 19. Children Long-Acting Growth Hormone Sales Share by Manufacturers in 2022
Figure 20. Global Children Long-Acting Growth Hormone Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Children Long-Acting Growth Hormone Players: Market Share by Revenue in 2022
Figure 22. Children Long-Acting Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Children Long-Acting Growth Hormone Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Children Long-Acting Growth Hormone Sales Market Share by Country (2024-2034)
Figure 25. North America Children Long-Acting Growth Hormone Revenue Market Share by Country (2024-2034)
Figure 26. United States Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Children Long-Acting Growth Hormone Sales Market Share by Country (2024-2034)
Figure 29. Europe Children Long-Acting Growth Hormone Revenue Market Share by Country (2024-2034)
Figure 30. Germany Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Children Long-Acting Growth Hormone Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Children Long-Acting Growth Hormone Revenue Market Share by Region (2024-2034)
Figure 37. China Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Children Long-Acting Growth Hormone Sales Market Share by Country (2024-2034)
Figure 45. Latin America Children Long-Acting Growth Hormone Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Children Long-Acting Growth Hormone Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Children Long-Acting Growth Hormone Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Children Long-Acting Growth Hormone Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Children Long-Acting Growth Hormone by Type (2024-2034)
Figure 55. Global Revenue Market Share of Children Long-Acting Growth Hormone by Type (2024-2034)
Figure 56. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of Children Long-Acting Growth Hormone by Application (2024-2034)
Figure 58. Global Revenue Market Share of Children Long-Acting Growth Hormone by Application (2024-2034)
Figure 59. Global Children Long-Acting Growth Hormone Price (US$/Unit) by Application (2024-2034)
Figure 60. Children Long-Acting Growth Hormone Value Chain
Figure 61. Children Long-Acting Growth Hormone Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed